Recruiting

Biorepository Development

Sponsor:

University of Kansas Medical Center

Code:

NCT03413982

Conditions

Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Registry

Study Details

Brief summary:

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Conditions

Bladder Cancer

Study ID

NCT03413982

Start date

Nov 2, 2017

Status verified date

Mar, 2026

Completion date

Jan 1, 2035

Anticipated

Primary completion date

Jan 1, 2035

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
  • Patients can participate in any additional research studies during the patients' participation within this protocol.

Exclusion Criteria:

  • Patients who do not have presumed bladder cancer will not be eligible

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

BC Patients

Patients with bladder cancer. This registry involves no intervention. Blood, urine, and tissue samples will be collected to be used for research.

Interventions

Registry

Patient registry

Primary outcome measure

  • Blood, urine and tissue characteristics of bladder cancer patients [ Time Frame: 24 months ]

Central Contacts and Locations

Central contacts

Jane Ladesma

913-588-8721jledesma2@kumc.edu

Locations

University of Kansas Medical Center

Recruiting

Kansas City, Kansas, United States, 66160

More Information

Sponsor

University of Kansas Medical Center

Last update posted

Mar 10, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Kansas Medical Center on 2026-03-10.